SCHEMBL2833288

SCHEMBL2833288

CN(C)C(=O)Oc1ccc(CCC(=O)N2CCC(N3CCCC3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 3/20 0.60
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 2/20 0.59
TSHR P16473 1/20 0.59
TDP1 Q9NUW8 3/20 0.48
MAPT P10636 2/20 0.48
CYP2D6 P10635 2/20 0.47
CYP1A2 P05177 1/20 0.47
ACHE P22303 1/20 0.46
MEN1 O00255 1/20 0.46
FKBP1A P62942 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 1/20 0.44
NAAA Q02083 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4391684 0.91 ALDH1A1 (0.72) L3MBTL3KMT2AALDH1A1TSHRMAPT
SCHEMBL4380538 0.90 ALDH1A1 (0.74) L3MBTL3KMT2AALDH1A1TSHRMAPT
SCHEMBL2833225 0.85 KMT2A (0.80) L3MBTL3KMT2AALDH1A1TSHRTDP1
SCHEMBL13636494 0.81 ALDH1A1 (0.69) L3MBTL3KMT2AALDH1A1TSHRFKBP1A
SCHEMBL14218117 0.79 GAA (0.53) KMT2AALDH1A1TSHRMEN1FKBP1A
SCHEMBL2833214 0.78 KMT2A (0.69) L3MBTL3KMT2AALDH1A1TSHRTDP1
SCHEMBL4381831 0.76 RAB9A (0.55) KMT2AALDH1A1TSHRMEN1FKBP1A
SCHEMBL4383272 0.75 ALDH1A1 (0.98) L3MBTL3KMT2AALDH1A1TSHRMEN1
SCHEMBL2833221 0.75 L3MBTL3 (0.59) L3MBTL3KMT2AALDH1A1TSHRTDP1
SCHEMBL23682658 0.75 L3MBTL3 (1.00) L3MBTL3KMT2AALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed